EUVIMEDEUVIMED entdecken
Crossref

Dual Regulation of ACSL3 by TRIM33-Mediated Ubiquitination and NBR1-Dependent Autophagy: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury

Yueqing Yang, Ming Zhao, Yibo Feng, Hongli Yu, Yuanxin Gong, Qingqing Liu iD

Antioxidants & Redox Signaling · 2026

DOI: 10.1177/15230864261470736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2026. Verfasst von Yueqing Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: Reperfusion Injury, Autophagy, Coenzyme A Ligases, Brain Ischemia. Die Arbeit nennt 40 Literaturangaben. Gefördert von: the Youth Medical Talent Training Program of the First Affiliated Hospital of Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral ischemia-reperfusion injury (CIRI) is a key contributor to stroke-related neurological damage, but the functional interplay between autophagy and ferroptosis—two critical pathological processes—remains poorly understood.

Methods

Using oxygen-glucose deprivation/reperfusion in PC12 cells and middle cerebral artery occlusion (MCAO) in rats, we combined molecular, pharmacological, and imaging approaches to investigate how autophagy regulates the ferroptosis suppressor acyl-CoA synthetase long-chain family member 3 (ACSL3).

Results

Ischemia-reperfusion triggered hyperactivated autophagy, which promoted ferroptosis by selectively targeting ACSL3 for degradation via the autophagy receptor neighbor of BRCA1 gene 1 protein (NBR1). We further identified that tripartite motif-containing protein 33 (TRIM33), an E3 ubiquitin ligase induced after ischemia, directly ubiquitinates ACSL3 and facilitates its proteasomal degradation. This ubiquitin-mediated pathway acted synergistically with autophagy to control ACSL3 stability. Pharmacological inhibition of autophagy with curcumin derivative 5g (CUR5g) restored ACSL3 protein levels and suppressed ferroptosis. In MCAO rats, CUR5g—administered alone or in combination with the ferroptosis inhibitor Ferfluor-1—significantly improved functional recovery and reduced brain injury.

Conclusion

Our study reveals a novel autophagy–NBR1/TRIM33–ACSL3 regulatory axis that drives ferroptosis in CIRI, highlighting a promising therapeutic strategy for ischemic stroke through cotargeting autophagy and ferroptosis. Antioxid. Redox Signal. 45, 676–692.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryAutophagyCoenzyme A LigasesBrain IschemiaUbiquitin-Protein LigasesTranscription FactorsAnimalsRatsUbiquitinationPC12 CellsFerroptosisMaleHumansLong-Chain-Fatty-Acid-CoA LigaseDisease Models, Animal

Stichwörter der Autor:innen

ACSL3NBR1TRIM33autophagycerebral ischemia-reperfusion injury (CIRI)ferroptosis

Substanzen

Coenzyme A LigasesUbiquitin-Protein LigasesTranscription FactorsLong-Chain-Fatty-Acid-CoA Ligase

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • The electromyography (EMG) room of the Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Biosafety Department, School of Basic Medical Sciences, Army Medical University, Chongqing, China.
  • Laboratory Department, The 962nd Hospital of the PLA Joint Logistic Support Force, Harbin, China.

ORCID-Profile: Qingqing Liu

Förderung

  • the Youth Medical Talent Training Program of the First Affiliated Hospital of Harbin Medical University

Zitieren

APA

Yang, Y., Zhao, M., Feng, Y., Yu, H., Gong, Y., & Liu, Q. (2026). Dual Regulation of ACSL3 by TRIM33-Mediated Ubiquitination and NBR1-Dependent Autophagy: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864261470736

Vancouver

Yang Y, Zhao M, Feng Y, Yu H, Gong Y, Liu Q. Dual Regulation of ACSL3 by TRIM33-Mediated Ubiquitination and NBR1-Dependent Autophagy: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury. Antioxidants & Redox Signaling. 2026. doi:10.1177/15230864261470736

BibTeX
@article{Yang2026,
  author = {Yang, Yueqing and Zhao, Ming and Feng, Yibo and Yu, Hongli and Gong, Yuanxin and Liu, Qingqing},
  title = {Dual Regulation of ACSL3 by TRIM33-Mediated Ubiquitination and NBR1-Dependent Autophagy: A Therapeutic Target for Cerebral Ischemia-Reperfusion Injury},
  journal = {Antioxidants & Redox Signaling},
  year = {2026},
  doi = {10.1177/15230864261470736}
}
Kostenlos starten →